- Report
- August 2025
- 189 Pages
Global
From €3136EUR$3,545USD£2,712GBP
€3485EUR$3,939USD£3,013GBP
- Report
- August 2025
- 199 Pages
Global
From €3136EUR$3,545USD£2,712GBP
€3485EUR$3,939USD£3,013GBP
- Report
- August 2025
- 144 Pages
Global
From €2795EUR$3,160USD£2,417GBP
€3494EUR$3,950USD£3,022GBP
- Report
- July 2025
- 274 Pages
Global
From €4419EUR$4,995USD£3,821GBP
- Report
- January 2025
- 92 Pages
Global
From €3500EUR$4,238USD£3,133GBP
- Report
- April 2025
- 130 Pages
Global
From €3647EUR$4,123USD£3,154GBP
€4291EUR$4,850USD£3,710GBP
- Report
- June 2025
- 103 Pages
Global
From €3052EUR$3,450USD£2,639GBP
- Report
- September 2024
- 138 Pages
Global
From €2653EUR$2,999USD£2,294GBP
- Report
- July 2024
- 175 Pages
Global
From €2212EUR$2,500USD£1,913GBP
- Report
- April 2021
Global
From €3937EUR$4,450USD£3,404GBP
- Report
- May 2023
- 97 Pages
Global
From €3500EUR$4,238USD£3,133GBP
- Book
- April 2018
- 424 Pages
Tissue Scaffolds are advanced materials used in tissue engineering and regenerative medicine. They are designed to provide a three-dimensional structure for cells to attach and grow on, and to provide a supportive environment for the cells to differentiate and form new tissue. Tissue scaffolds are typically made from biodegradable polymers, such as polylactic acid, polyglycolic acid, and polycaprolactone, and can be further modified with proteins, peptides, and other molecules to improve their performance.
Tissue scaffolds are used in a variety of medical applications, including wound healing, bone regeneration, and drug delivery. They are also used in research to study the effects of drugs on cells and to develop new treatments for diseases.
Companies in the Tissue Scaffolds market include Corbion, Poly-Med, Inc., NuSil Technology, and PolyNovo Ltd. Show Less Read more
